EDGAR Filing Documents for 0000950170-24-114787

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000950170-24-114787

Filing Date

2024-10-15

Accepted

2024-10-15 18:00:06

Documents

Period of Report

2024-10-13

Document Format Files

Seq	Description	Document	Type	Size
1	4	ownership.html	4
1	4	ownership.xml	4	7497
	Complete submission text file	0000950170-24-114787.txt		8915

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300

Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600

CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CRISPR THERAPEUTICS, INC. 610 MAIN STREET CAMBRIDGE MA 02139

Business Address

KASINGER JAMES R. (Reporting) CIK: 0001708172 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 241372924